Product Wiki · Recalls · EU Safety Gate (RAPEX)

Tattoo Ink White C.i.77491 — recall SR/00419/25

EU Safety Gate (RAPEX) · Germany · 2025-01-31 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/00419/25
Date of alert
2025-01-31
Country / jurisdiction
Germany
Risk level
Serious risk
Risk type
Chemical
Brand
INTENZE
Product category
Chemical products
Product type
Tattoo ink
Reported risk: Das Produkt weist eine übermäßige Bleikonzentration auf (Messwert: 0,00019 Gewichtsprozent). Blei ist schädlich für die menschliche Gesundheit, reichert sich im Körper an und kann gestillte oder ungeborene Kinder beeinträchtigen. Das Produkt entspricht nicht der REACH-Verordnung.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Destruction of the product
Date of entry into force
06/01/2025
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Tattoo Ink White C.i.77491

Risk Description (original English): The product has an excessive concentration of lead (measured value: 0.00019% by weight). Lead is harmful to human health, accumulates in the body, and may affect breast-fed or unborn children.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10092832

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.